Richard N. Fedorak
0000-0002-7382-0080
Publication & Citation Trends
Publications
603 total
An overview of clinical decision support systems: benefits, risks, and strategies for success PDF
Cited by 2,655
OpenAlex
Systematic review with meta‐analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitis OA
Cited by 31
Semantic Scholar
Preoperative Ustekinumab Treatment is not Associated with Increased Postoperative Complications in crohn's Disease: A Canadian Multicentre Case–Control Cohort Study
Cited by 12
Semantic Scholar
Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's disease OA
Cited by 90
Semantic Scholar
The incidence rate of colectomy for medically refractory ulcerative colitis has declined in parallel with increasing anti‐TNF use: a time‐trend study
Cited by 101
Semantic Scholar
Adalimumab dose escalation is effective for managing secondary loss of response in Crohn's disease OA
Cited by 46
Semantic Scholar
A one‐hour infusion of infliximab during maintenance therapy is safe and well tolerated: a prospective cohort study OA
Cited by 37
Semantic Scholar
Research Topics
Inflammatory Bowel Disease
(281)
Microscopic Colitis
(200)
Helicobacter pylori-related gastroenterology studies
(75)
Gut microbiota and health
(69)
Eosinophilic Esophagitis
(55)
Affiliations
Semmelweis University
Universitat Autònoma de Barcelona
Western University
Alberta Health Services
Heritage Foundation